Developing novel therapeutic agents, diagnostics, and lifestyle recommendations that make possible the treatment of risk factors for cancer, with the focus on familial adenomatous polyposis, neuroblastoma and the prevention of recurrence in colon cancer survivors.
© 2018 DVI EQUITY PARTNERS a Diamond Ventures Company. All rights reserved. Privacy PolicySitemapWebsite by Caliber Group
